Open AccessLikelihood of myocardial infarction, revascularization and death following catheterization laboratory activation in patients with vs. without both chest pain and ST elevation
Author(s) -
Peter Puleo,
Philip Salen,
Yugandhar Manda,
Huseng Vefali,
Sahil Agrawal,
Abdullah Quddus,
Kevin M. Branch,
Melinda Shoemaker,
Jill Stoltzfus
Publication year - 2020
Publication title -
coronary artery disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.504
H-Index - 62
eISSN - 1473-5830
pISSN - 0954-6928
DOI - 10.1097/mca.0000000000000920
Subject(s) - medicine , chest pain , myocardial infarction , cardiology , revascularization , cardiac catheterization , elevation (ballistics) , geometry , mathematics
Emergent cardiac catheterization laboratory activation (CCLA) for patients with suspected ST-elevation myocardial infarction (STEMI) is employed to expedite acute revascularization (AR). The incidence of false-positive CCLA, in which AR is not performed, remains high. The combination of chest pain (CP) and electrocardiographic ST elevation (STE) are the hallmarks of STEMI. However, CCLA is sometimes initiated for patients lacking this combination. The study objective was to quantify the difference in likelihood of AR and mortality in patients with vs. without both CP and STE.